253 related articles for article (PubMed ID: 30217407)
1. Correlations between population-levels of prescription opioid dispensing and related deaths in Ontario (Canada), 2005-2016.
Fischer B; Jones W; Varatharajan T; Malta M; Kurdyak P
Prev Med; 2018 Nov; 116():112-118. PubMed ID: 30217407
[TBL] [Abstract][Full Text] [Related]
2. Patterns, Changes, and Trends in Prescription Opioid Dispensing in Canada, 2005-2016.
Fischer B; Jones W; Vojtila L; Kurdyak P
Pain Physician; 2018 May; 21(3):219-228. PubMed ID: 29871366
[TBL] [Abstract][Full Text] [Related]
3. Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005-2011.
Fischer B; Jones W; Urbanoski K; Skinner R; Rehm J
Drug Alcohol Rev; 2014 Jan; 33(1):19-26. PubMed ID: 24261474
[TBL] [Abstract][Full Text] [Related]
4. High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005-2009.
Fischer B; Jones W; Rehm J
Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):438-42. PubMed ID: 23319301
[TBL] [Abstract][Full Text] [Related]
5. Trends in dispensing of individual prescription opioid formulations, Canada 2005-2020.
Jones W; Kaoser R; Rudoler D; Fischer B
J Pharm Policy Pract; 2022 Mar; 15(1):27. PubMed ID: 35351208
[TBL] [Abstract][Full Text] [Related]
6. Correlations between opioid mortality increases related to illicit/synthetic opioids and reductions of medical opioid dispensing - exploratory analyses from Canada.
Fischer B; Jones W; Tyndall M; Kurdyak P
BMC Public Health; 2020 Jan; 20(1):143. PubMed ID: 32005211
[TBL] [Abstract][Full Text] [Related]
7. Trends and changes in prescription opioid analgesic dispensing in Canada 2005-2012: an update with a focus on recent interventions.
Fischer B; Jones W; Rehm J
BMC Health Serv Res; 2014 Feb; 14():90. PubMed ID: 24572005
[TBL] [Abstract][Full Text] [Related]
8. Patterns, trends and determinants of medical opioid utilization in Canada 2005-2020: characterizing an era of intensive rise and fall.
Jones W; Kaoser R; Fischer B
Subst Abuse Treat Prev Policy; 2021 Sep; 16(1):65. PubMed ID: 34521418
[TBL] [Abstract][Full Text] [Related]
9. Correlations between Changes in Medical Opioid Dispensing and Contributions of Fentanyl to Opioid-Related Overdose Fatalities: Exploratory Analyses from Canada.
Jones W; Lee MA; Kaoser R; Fischer B
Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299958
[TBL] [Abstract][Full Text] [Related]
10. Trends in high-dose opioid prescribing in Canada.
Gomes T; Mamdani MM; Paterson JM; Dhalla IA; Juurlink DN
Can Fam Physician; 2014 Sep; 60(9):826-32. PubMed ID: 25217680
[TBL] [Abstract][Full Text] [Related]
11. Examining correlations between opioid dispensing and opioid-related hospitalizations in Canada, 2007-2016.
Jones W; Kurdyak P; Fischer B
BMC Health Serv Res; 2020 Jul; 20(1):677. PubMed ID: 32698815
[TBL] [Abstract][Full Text] [Related]
12. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
13. The association between prescription opioid dispensing and opioid-related morbidity and mortality in Ontario, Canada: an ecological study of public health units.
Ladha KS; Wijeysundera DN; Wunsch H; Clarke H; Diep C; Gomes T
Drug Alcohol Depend; 2021 Oct; 227():108989. PubMed ID: 34482045
[TBL] [Abstract][Full Text] [Related]
14. Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims.
Karanges EA; Blanch B; Buckley NA; Pearson SA
Br J Clin Pharmacol; 2016 Jul; 82(1):255-67. PubMed ID: 26991673
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the population-level effects of oxycodone restrictions on prescription opioid utilization in Ontario.
Rudoler D; Kurdyak P; Gomes T; Huang A; Jones W; Littleford S; Paracha N; Fischer B
Pharmacoepidemiol Drug Saf; 2022 Jul; 31(7):769-778. PubMed ID: 35470515
[TBL] [Abstract][Full Text] [Related]
16. Prescription opioid dispensing and prescription opioid poisoning: Population data from Victoria, Australia 2006 to 2013.
Berecki-Gisolf J; Hassani-Mahmooei B; Clapperton A; McClure R
Aust N Z J Public Health; 2017 Feb; 41(1):85-91. PubMed ID: 27624336
[TBL] [Abstract][Full Text] [Related]
17. Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada.
Gomes T; Khuu W; Martins D; Tadrous M; Mamdani MM; Paterson JM; Juurlink DN
BMJ; 2018 Aug; 362():k3207. PubMed ID: 30158106
[TBL] [Abstract][Full Text] [Related]
18. Vital Signs: Pharmacy-Based Naloxone Dispensing - United States, 2012-2018.
Guy GP; Haegerich TM; Evans ME; Losby JL; Young R; Jones CM
MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(31):679-686. PubMed ID: 31393863
[TBL] [Abstract][Full Text] [Related]
19. Trends and uptake of new formulations of controlled-release oxycodone in Canada.
Gomes T; Jain S; Paterson JM; Sketris I; Caetano P; Henry D;
Pharmacoepidemiol Drug Saf; 2018 May; 27(5):520-525. PubMed ID: 29359446
[TBL] [Abstract][Full Text] [Related]
20. Changes in consumption of opioid analgesics in Israel 2009 to 2016: An update focusing on oxycodone and fentanyl formulations.
Ponizovsky AM; Marom E; Weizman A; Schwartzberg E
Pharmacoepidemiol Drug Saf; 2018 May; 27(5):535-540. PubMed ID: 29488288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]